Dr Jianda Yuan
Dr. Yuan currently is the Director of Translational Oncology at Early Oncology Development Department of Merck Research Laboratory. Before he joined Merck in February, 2016, He established and led the translational biomarker research at Ludwig Center for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center in the past decade. His research interest is translational medicine and biomarker discovery for immune checkpoint blockade immunotherapy with approximately 70 peer-reviewed articles, including publication in Science, NEJM, Nature Medicine, Nature Immunology, PNAS, Blood, Journal of Immunology, Clinical Cancer Research and Journal Immunotherapy of Cancer. He is a member of SITC, AACR and ASCO. Dr. Yuan is an Associate Editor of the Journal Immunotherapy of Cancer. He served as a Member of the steering committee for the CRI-CIC from 2006 to 2011. He is Group Chair of the SITC Biomarker Task Force.